UPDATE : Tuesday, October 23, 2018
상단여백
Shares of biotech firms, listed with ‘exceptional techs,’ rise above offer price
Most of the biotechnology companies, listed on Kosdaq early this year under...
by Nam Doo-hyun  |  2017-12-05 14:38
라인
Sewon seeks p3 clinical trials for cartilage cell therapy in Japan
Sewon Cellontech said Monday that Olympus RMS has submitted phase 3 clinica...
by Lee Han-soo  |  2017-12-04 16:17
라인
Cord blood biotech firms enjoy stock price gains this year
Korean biotech firms with major pipelines in cord blood banks and umbilical...
by Nam Doo-hyun  |  2017-12-04 15:02
라인
Nature Cell’s clinical trial on Alzheimer therapy running smoothly
Nature Cell said Monday that it has injected 10 doses of Astrostem, a stem-...
by Lee Han-soo  |  2017-12-04 14:57
라인
FDA approves clinical trial for Pharmicell’s liver cirrhosis treatment
Pharmicell said Monday that the U.S. Food and Drug Administration has appro...
by Lee Han-soo  |  2017-12-04 14:57
라인
Tego Science shares surge on robust earnings
The surging of Tego Science shares on Kosdaq on Thursday drew attention, pr...
by Nam Doo-hyun  |  2017-12-01 11:48
라인
Panagene wins patent for molecular diagnostic platform
Panagene said Thursday that it has completed its patent registration for PA...
by Lee Han-soo  |  2017-12-01 11:02
라인
Medipost hits record vial sales for Cartistem
Medipost said Thursday that it hit record sales of 266 vials for Cartistem,...
by Lee Han-soo  |  2017-11-30 16:16
라인
Biopharmaceutical firms' liver treatments draw attention
Local biopharmaceutical companies, including Sillajen, HLB, and Pharmicell,...
by So Jae-hyeon  |  2017-11-30 12:02
라인
What are doctors’ views on Invossa used even by foreign patients?
An increasing number of patients here are trying to obtain Invossa-K, an os...
by Lee Hye-seon  |  2017-11-29 09:31
라인
Green Cross, Feldan start joint tech development
Green Cross Labcell and Feldan Therapeutics, a Canadian biotechnology compa...
by Lee Han-soo  |  2017-11-27 16:59
라인
Foreigners dump Medytox, Hugel; buy Celltrion, ViroMed
On Korea’s secondary stock market, foreign investors net bought the shares ...
by Nam Doo-hyun  |  2017-11-27 13:13
라인
Biogen Korea taps new CEO
Biogen Korea, the Korean branch of the American multinational biotech Bioge...
by Marian Chu  |  2017-11-27 11:57
라인
Clinical trials on CAR-T cell therapies surge in two years
The number of clinical trials on CAR-T (chimeric antigen receptor T-cell) t...
by Nam Doo-hyun  |  2017-11-24 15:53
라인
Kolon okayed for clinical trial to expand treatment for Invossa-K injection
The Ministry of Food and Drug Safety (MFDS) has approved Kolon Life Science...
by Lee Han-soo  |  2017-11-23 15:53
라인
GemVax & KAEL confirms potential tracer effective to reperfusion injury
A study conducted by the Seoul National University has confirmed that GV100...
by Constance Williams  |  2017-11-22 15:51
라인
COGIB spotlights future of innovative biotherapeutic
The Coordinating Center for Global Innovative Biotherapeutics (COGIB) analy...
by Lee Han-soo  |  2017-11-22 11:06
라인
KAEL confirms potential tracer as treatment for kidney cancer
GemVax & KAEL said a research article that confirms the potential of GV1001...
by Constance Williams  |  2017-11-20 15:44
라인
Samsung Bioepis wins European sales approval for Ontruzant
The European Commission (EC) has granted marketing authorization for Samsun...
by Lee Han-soo  |  2017-11-20 10:48
라인
ViroMed aims phase 1 trial on CAR-T cell therapy by 2020-2022
ViroMed said it would conduct a phase 1 clinical trial on CAR-T (chimeric a...
by Nam Doo-hyun  |  2017-11-17 13:53
여백
여백
여백
Back to Top